WhiteLab Genomics uses AI to accelerate genomic medicine development. Its platform, ALFRED, analyzes complex biological data to design therapies via in-silico simulations. Partnering with leaders like Sanofi, it cuts costs, shortens timelines, and boosts success rates. WhiteLab Genomics is backed by Y-Combinator and is part of the prestigious French Tech 2030 program and recently joined the Bayer Co.Lab in Cambridge, MA.
